T. Trarbach, M. Moehler, V. Heinemann, C. H. Kohne, M. Przyborek, C. Schulz, V. Sneller, G. Gallant and S. Kanzler, “Phase II Trial of Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets and Activates the Tumour Necrosis Factor Apoptosis-Inducing Ligand Receptor-1 (TRAIL-R1), in Patients with Refractory Colorectal Cancer,” British Journal of Cancer, Vol. 102, No. 3, 2010, pp. 506-512. http://dx.doi.org/10.1038/sj.bjc.6605507

has been cited by the following article:

• TITLE: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies

  AUTHORS: Anita C. Bellail, Chunhai Hao

  KEYWORDS: Apoptosis Pathway; Apoptosis Pathway

  JOURNAL NAME: Open Journal of Apoptosis, Vol.2 No.4, October 31, 2013

  ABSTRACT: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies